Rescue of p53 functions by in vitro-transcribed mRNA impedes the growth of high-grade serous ovarian cancer.
Monika RaabIzabela KostovaSamuel Peña-LlopisDaniela FietzMonika KressinSeyed Mohsen AberoumandiEvelyn UllrichSven BeckerMourad SanhajiKlaus StrebhardtPublished in: Cancer communications (London, England) (2023)
The IVT mRNA-based reactivation of p53 holds promise as a potential therapeutic strategy for HGSOC, providing valuable insights into the molecular mechanisms underlying p53 function and its relevance in ovarian cancer treatment.